Literature DB >> 20372943

Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.

Taleen Der-Ghazarian1, Sergios Charntikov, Fausto A Varela, Cynthia A Crawford, Sanders A McDougall.   

Abstract

The purpose of the present study was to determine whether repeated treatment with the D2 partial agonist aripiprazole or the D2 antagonist haloperidol alters dopamine (DA) synthesis characteristics in the dorsal striatum of young rats. To this end, rats received a daily pretreatment regimen of aripiprazole or haloperidol on postnatal days (PD) 10-20 and were tested 24 or 72 h later after an acute injection of vehicle, aripiprazole, haloperidol, or quinpirole (a D2 agonist). For comparison purposes, adult rats were pretreated with an 11-day regimen of saline or haloperidol on PD 70-80 and DA synthesis was measured after acute drug treatment on PD 83. Dorsal striatal DA synthesis was determined by measuring L-dihydroxyphenylalanine accumulation after NSD-1015 treatment. In a separate experiment, the ability of repeated drug treatment to up-regulate dorsal striatal D2 receptors was assessed in young and adult rats 72 h after drug discontinuation. The major findings of this study were that: (a) acute treatment with haloperidol and aripiprazole increased DA synthesis while quinpirole reduced it; (b) pretreatment with haloperidol and aripiprazole blunted the synthesis-modulating effects of acutely administered dopaminergic drugs; and (c) DA synthesis of young and adult rats was affected in a qualitatively similar manner by DA agonist, antagonist, and partial agonist drugs. In conclusion, results from the present study suggest that synthesis-modulating autoreceptors in the dorsal striatum are functionally mature by the end of the preweanling period and DA synthesis declines to near basal levels during the course of repeated aripiprazole treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372943     DOI: 10.1007/s00702-010-0396-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  71 in total

Review 1.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

2.  Case series on the use of aripiprazole for Tourette syndrome.

Authors:  Tanya K Murphy; Michael A Bengtson; Ohel Soto; Paula J Edge; Muhammad W Sajid; Nathan Shapira; Mark Yang
Journal:  Int J Neuropsychopharmacol       Date:  2005-04-28       Impact factor: 5.176

3.  Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.

Authors:  M Geurts; E Hermans; J Cumps; J M Maloteaux
Journal:  Brain Res       Date:  1999-09-11       Impact factor: 3.252

4.  Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.

Authors:  K Svensson; A Ekman; M F Piercey; W E Hoffmann; J T Lum; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

5.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species.

Authors:  R R Holson; B Pearce
Journal:  Neurotoxicol Teratol       Date:  1992 May-Jun       Impact factor: 3.763

Review 6.  Use of atypical antipsychotics in the treatment of autistic disorder.

Authors:  Joan M Stachnik; Cheryl Nunn-Thompson
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

Review 7.  Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

8.  Dopamine D2(High) receptors moderately elevated by bifeprunox and aripiprazole.

Authors:  Philip Seeman
Journal:  Synapse       Date:  2008-12       Impact factor: 2.562

9.  Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.

Authors:  R J Baldessarini; E R Marsh; D Huston-Lyons
Journal:  Biochem Pharmacol       Date:  1994-05-18       Impact factor: 5.858

10.  A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Authors:  Ronald N Marcus; Randall Owen; Lisa Kamen; George Manos; Robert D McQuade; William H Carson; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-11       Impact factor: 8.829

View more
  6 in total

1.  Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.

Authors:  Fausto A Varela; Taleen Der-Ghazarian; Ryan J Lee; Sergios Charntikov; Cynthia A Crawford; Sanders A McDougall
Journal:  J Psychopharmacol       Date:  2013-09-17       Impact factor: 4.153

2.  Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.

Authors:  Sanders A McDougall; Alena Mohd-Yusof; Graham J Kaplan; Zuhair I Abdulla; Ryan J Lee; Cynthia A Crawford
Journal:  Eur J Pharmacol       Date:  2013-02-28       Impact factor: 4.432

3.  Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.

Authors:  Hiroshi Ito; Harumasa Takano; Ryosuke Arakawa; Hidehiko Takahashi; Fumitoshi Kodaka; Keisuke Takahata; Tsuyoshi Nogami; Masayuki Suzuki; Tetsuya Suhara
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

4.  Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.

Authors:  Bo Pan; Jiezhong Chen; Jiamei Lian; Xu-Feng Huang; Chao Deng
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.

Authors:  Michael De Santis; Jiamei Lian; Xu-Feng Huang; Chao Deng
Journal:  Int J Mol Sci       Date:  2016-11-22       Impact factor: 5.923

Review 6.  Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti; Felice Iasevoli
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.